Annals of the American Thoracic Society
July 1, 2026
2 min readIP Score 10/10
The complementary roles of endobronchial ultrasound-guided needle aspiration, mini-forceps, and cryobiopsy in the investigation of mediastinal lesions.
BACKGROUND: Convex probe endobronchial ultrasound (EBUS) bronchoscopy-guided transbronchial needle aspiration (TBNA) is the mainstay of mediastinal and hilar lesion sampling, and EBUS-TBNA allows for the acquisition of cytologic material. However, certain clinicopathologic conditions require the acquisition of histopathologic specimens. This can be accomplished via EBUS-guided transbronchial mini-forceps biopsy (TBFB) and cryobiopsy (TBCB), but the incremental value of these -modalities in various clinicopathologic conditions has yet to be explored. OBJECTIVE: Define the incremental value of EBUS-guided TBFB and TBCB over TBNA via evaluation of diagnostic yield, tissue quality, and adequacy for ancillary assays. METHODS: All patients who underwent EBUS-TBNA supplemented by TBFB and/or TBCB across 2 large academic centers were reviewed retrospectively. Cytology and histopathology tissue specimens were scrutinized for quantity, quality, tissue diagnosis, and adequacy for immunohistochemistry, molecular assays, and flow cytometry. Comparisons were made across TBNA, TBFB, and TBCB, as well as with a control group of EBUS-TBNA-only procedures for safety and procedural duration. RESULTS: A total of 204 lesions were sampled in 156 patients. Overall diagnostic yield was similar across TBNA, TBFB, and TBCB (P = .7); however, TBFB and TBCB outperformed TBNA for the diagnosis of lymphoproliferative and inflammatory conditions (P = .03 and P < .001, respectively). Compared with TBNA and TBFB, TBCB provided higher-quality tissue for immunohistochemistry and molecular profiling assays (P = .002 and P < .001, respectively). Adequacy of TBNA for flow cytometry outperformed that of TBFB and TBCB (P < .001). Compared with TBFB, TBCB tissue specimens provided more diagnostic tissue (P < .0001) with less crush artifact (P < .0001). The rate and severity of procedure-related complications were similar across study cases and the EBUS-TBNA-only control group. CONCLUSIONS: For the sampling of mediastinal and hilar lesions, supplementation of EBUS-TBNA by TBFB or TBCB should be primarily considered when suspecting a lymphoproliferative or an inflammatory etiology or when high-quality tissue is -required for predictive immunohistochemistry and molecular assays. For accurate diagnosis and classification of lymphomas, the combination of TBNA for flow cytometry with TBCB for histopathologic interpretation appears to be optimal.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.